You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 19, May 19, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Pulmonary Diseases, Other
 •Alert me on articles by topic

Closer to a Cure for the Common Cold?

Kenneth McIntosh, MD

JAMA. 1999;281:1844-1845.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The search for a "cure for the common cold" resembles in some ways a late 20th-century quest for the holy grail, and although new and remarkable medical discoveries are reported almost daily, the skeptics reiterate that medicine still cannot cure the most frequent infectious disease, the common cold. It is not that accomplished scientists have not tried, and the literature is filled with accounts of these attempts. But the goal has evaded researchers for years, and it is in this context that we should evaluate the report of Turner and colleagues1 in this issue of THE JOURNAL.

The approaches to research into treatment of the common cold can be roughly divided into 2 large categories: the antiviral and the anti-inflammatory. Acute viral respiratory tract infections are brief events, in which symptoms first appear when the immune response is already active, and, in most instances, the virus is . . . [Full Text of this Article]

Author Affiliation: Division of Infectious Diseases, Children's Hospital, Harvard Medical School, Boston, Mass.


RELATED ARTICLE

Efficacy of Tremacamra, a Soluble Intercellular Adhesion Molecule 1, for Experimental Rhinovirus Infection: A Randomized Clinical Trial
Ronald B. Turner, Margaret T. Wecker, Gerhardt Pohl, Theodore J. Witek, Eugene McNally, Roger St. George, Birgit Winther, and Frederick G. Hayden
JAMA. 1999;281(19):1797-1804.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Changes in Rhinovirus Protein 2C Allow Efficient Replication in Mouse Cells
Harris and Racaniello
J. Virol. 2003;77:4773-4780.
ABSTRACT | FULL TEXT  

Promising New Agent for Rhinovirus Infections
JWatch Infect. Diseases 1999;1999:4-4.
FULL TEXT  

High-Tech Treatment for the Common Cold
Journal Watch Dermatology 1999;1999:15-15.
FULL TEXT  

High-Tech Treatment for the Common Cold
JWatch General 1999;1999:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.